FDA approves Sanofi's Gaucher disease drug Cerdelga

[riky]

FDA approves Sanofi's Gaucher disease drug Cerdelga

Food and Drug Administration said on Tuesday it has approved Sanofi SA's drug Cerdelga to treat patients with type 1 Gaucher disease, a rare genetic disorder. The drug was developed by Sanofi's Genzyme unit, which also developed the Gaucher disease drug Cerezyme. Gaucher disease is caused by deficient levels of an enzyme needed to break down certain fats, leading to enlarged liver and spleen. Dr. David Meeker, Genzyme's chief executive, said in an interview that the company plans to price the drug on a par with Cerezyme, which has an average annual cost of about $300,000.

Source: You are not allowed to view links. Register or Login